Sputnik vaccine is 90 percent effective against delta variants: Scientist

Russia’s Sputnik, the viral carrier and messenger vaccine, is very effective against the new variant Delta of the corona and provides 90 percent protection. This information has been given by Sergei Nitisov, a member of the Russian Academy of Sciences (RAS) and head of the Novobryansk University Laboratory.

Nitisov said that according to data received from the US, Britain and other countries, messenger RNA and carrier vaccines including Sputnik V are effective against delta virus and are 95 percent effective against the initial strain and 90 percent against the delta variant of the virus. . He also said that the vaccines that have been made earlier should also be used as they have also been found to be effective.

The Sputnik vaccine has been made by Russia’s Gamelya Research Center and Russia is the first country in the world to register this vaccine against the corona virus in August 2020. This vaccine, also called Gam-Covid-Vax, uses two different types of engineered adenoviruses (RAD26 and RAD5) for the first and second doses, which enter human cells and bind to the spike protein of the corona virus. Delivers the code. Adenoviruses cause very mild disease symptoms in humans and have been used in comparison to Oxford’s AstraZeneca and Johnson & Johnson vaccines.

According to an interim analysis published in the scientific journal Lancet, the efficacy of the Sputnik vaccine is 91.6 percent. A special feature of this vaccine is that it does not form blood clots in the human body as compared to Oxford-AstraZeneca and Johnson & Johnson vaccines. Spoonic vaccine is being used in more than 60 countries of the world.